Brachytherapy Alone (BT) Without Supplemental External Beam Radiation Therapy (EBRT) May be Sufficient in Management of Intermediate Risk Prostate Cancer

被引:0
|
作者
Shah, Amit [1 ]
Bell, Ted [2 ]
Fortier, Gregory [1 ]
机构
[1] York Canc Ctr, York, PA USA
[2] York Hosp, Dept Res, York, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
39
引用
收藏
页码:210 / 210
页数:1
相关论文
共 50 条
  • [1] Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy
    Markovic, Emily Schlussel
    Buckstein, Michael
    Stone, Nelson N.
    Stock, Richard G.
    [J]. BJU INTERNATIONAL, 2018, 121 (05) : 774 - 780
  • [2] External beam (EBRT) and HDR brachytherapy (BT) in prostate cancer: impact of EBRT volume
    Tharmalingam, H.
    Tsang, Y.
    Choudhury, A.
    Hoskin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S146 - S147
  • [3] External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Alonzi, Roberto
    Wylie, James
    Ahmed, Imtiaz
    Henry, Ann
    Heath, Catherine
    Hoskin, Peter J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 525 - 533
  • [4] Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer
    Andruska, Neal
    Michalski, Jeff M.
    Carmona, Ruben
    Agabalogun, Temitope
    Brenneman, Randall J.
    Gay, Hiram A.
    Fischer-Valuck, Benjamin W.
    Baumann, Brian C.
    [J]. BRACHYTHERAPY, 2022, 21 (03) : 317 - 324
  • [5] Supplemental Androgen Deprivation Therapy Is More Beneficial Than Supplemental External Beam Radiation Therapy for Men with Unfavorable Intermediate Risk Prostate Cancer Treated with Brachytherapy
    King, M.
    Nguyen, P. L.
    Chen, M. H.
    Moran, B. J., Jr.
    Braccioforte, M. H.
    DAmico, A. V.
    Buzurovic, I.
    Devlin, P. M.
    Orio, P. F., III
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E247 - E247
  • [6] HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) COMBINED WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) IN PATIENTS WITH PROSTATE CANCER
    Inomata, T.
    Shimbo, T.
    Takahashi, M.
    Uesugi, Y.
    Azuma, H.
    Katsuoka, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S327 - S327
  • [7] Hormonal Therapy or External Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer
    Rosenberg, J. E.
    Chen, M.
    Nguyen, P. L.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S367 - S368
  • [8] Predictors of the Use of Supplemental Androgen Suppression Therapy (AST) and External Beam Radiation Therapy (EBRT) in Men with High-risk Prostate Cancer (PC) Undergoing Brachytherapy
    Hattangadi, J. A.
    Chen, M.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S577 - S578
  • [9] Treatment Results of Brachytherapy Versus External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer
    Goy, B. W.
    Soper, M. S.
    Chang, T.
    Slezak, J. M.
    Cosmatos, H.
    Tome, M. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E193 - E193
  • [10] Treatment results of brachytherapy versus external beam radiation therapy for intermediate risk prostate cancer.
    Goy, Barry W.
    Soper, Margaret S.
    Chang, Tangel
    Cosmatos, Harry A.
    Slezak, Jeff M.
    Tome, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)